2,888 Shares of Danaher Corporation $DHR Bought by KRS Capital Management LLC

KRS Capital Management LLC purchased a new position in shares of Danaher Corporation (NYSE:DHR) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 2,888 shares of the conglomerate’s stock, valued at approximately $640,000.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. BlackRock Inc. acquired a new stake in shares of Danaher during the second quarter worth about $10,492,520,000. Wellington Management Group LLP grew its holdings in shares of Danaher by 10.4% in the second quarter. Wellington Management Group LLP now owns 16,316,834 shares of the conglomerate’s stock valued at $3,108,031,000 after purchasing an additional 1,542,310 shares in the last quarter. Jupiter Topco LLC acquired a new position in shares of Danaher in the second quarter valued at approximately $1,456,317,000. Generation Investment Management LLP acquired a new position in shares of Danaher in the second quarter valued at approximately $1,287,949,000. Finally, Bank of America Corp DE purchased a new stake in Danaher during the 2nd quarter worth approximately $993,846,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Stock Performance

Shares of Danaher stock opened at $228.87 on Friday. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The company has a market cap of $160.89 billion, a PE ratio of 40.65, a P/E/G ratio of 2.88 and a beta of 0.76. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The business has a 50-day simple moving average of $214.04 and a 200-day simple moving average of $195.97.

Danaher (NYSE:DHR) last released its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.77 earnings per share. On average, equities research analysts forecast that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 0.7%. The ex-dividend date is Wednesday, September 30th. Danaher’s payout ratio is 28.42%.

Analyst Upgrades and Downgrades

DHR has been the topic of a number of research reports. Wells Fargo & Company reduced their target price on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a report on Wednesday, July 22nd. Morgan Stanley raised their price target on shares of Danaher from $220.00 to $240.00 and gave the company an “overweight” rating in a research report on Monday, October 12th. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $240.00 price target on shares of Danaher in a research note on Wednesday, July 22nd. Stifel Nicolaus cut their price objective on Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a research report on Wednesday, July 22nd. Finally, Weiss Ratings raised Danaher from a “hold (c-)” rating to a “hold (c)” rating in a research report on Wednesday, September 16th. Two equities research analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and a consensus price target of $235.41.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.